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Small ﬁeld dosimetryPurpose: The goal of this work was to set out a methodology for measuring and reporting small ﬁeld rel-
ative output and to assess the application of published correction factors across a population of linear
accelerators.
Methods and materials: Measurements were made at 6 MV on ﬁve Varian iX accelerators using two PTW
T60017 unshielded diodes. Relative output readings and proﬁle measurements were made for nominal
square ﬁeld sizes of side 0.5 to 1.0 cm. The actual in-plane (A) and cross-plane (B) ﬁeld widths were taken





and is presented as a ﬁeld size metric. FSeff was used to linearly interpolate between published Monte
Carlo (MC) calculated kfclin ;fmsrQclin ;Qmsr values to correct for the diode over-response in small ﬁelds.
Results: The relative output data reported as a function of the nominal ﬁeld size were different across the
accelerator population by up to nearly 10%. However, using the effective ﬁeld size for reporting showed
that the actual output ratios were consistent across the accelerator population to within the experimental
uncertainty of ±1.0%. Correcting the measured relative output using kfclin ;fmsrQclin ;Qmsr at both the nominal and
effective ﬁeld sizes produce output factors that were not identical but differ by much less than the
reported experimental and/or MC statistical uncertainties.
Conclusions: In general, the proposed methodology removes much of the ambiguity in reporting and
interpreting small ﬁeld dosimetric quantities and facilitates a clear dosimetric comparison across a pop-
ulation of linacs.
 2013 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 109 (2013) 350–355The International Electrotechnical Commission (IEC) recom-
mends using the distance intercepted by a given isodose curve
(50% level) on a plane perpendicular to the beam axis, at a stated
ﬁxed distance from the source (isocenter), to deﬁne the dosimetric
ﬁeld size [1]. Often in clinical practice the deﬁnition of ﬁeld size is
more loosely taken to mean the light ﬁeld projection at a ﬁxed dis-
tance from the source. In the somewhat dated ICRU Report 24 [2]
the light ﬁeld projection is deﬁned as the geometric ﬁeld size.
For ﬁeld sizes large enough to ensure no source occlusion and
charged particle equilibrium (CPE) the geometric ﬁeld size may
provide an accurate representation of the dosimetric ﬁeld size, at
least to within a given clinical tolerance. However, Das et al. [3]
have reported that for ﬁeld sizes that do not satisfy the CPE or
occlusion criteria the dosimetric ﬁeld size will be greater than
the geometric ﬁeld size and therefore the traditional close agree-
ment between ﬁeld size deﬁnitions breaks down.Experimental small ﬁeld dosimetry can be challenging due to
the lack of lateral charged particle equilibrium, spectral changes
as a function of ﬁeld size, detector choice and subsequent pertur-
bations of the charged particle ﬂuence [3]. Alfonso et al. [4] have
presented a well thought out dosimetry formalism for reporting
corrected relative output factors for small and non-standard ﬁelds.
The formalism makes use of a ﬁeld factor (O) which converts ab-
sorbed dose to water for the machine-speciﬁc reference ﬁeld (fmsr)
to that of the clinical ﬁeld of interest (fclin). This ﬁeld factor is equal
to the ratio of experimental detector readings (ORfclindet ) multiplied by
a detector-speciﬁc correction factor (kfclin ;fmsrQclin ;Qmsr ). Although the for-
malism establishes a framework for correcting small ﬁeld relative
output measurements it could be argued that the reporting, and
application, of kfclin ;fmsrQclin ;Qmsr as a function of ﬁeld size is still somewhat
ambiguous.
Commercial diode detectors have been shown to be a reason-
ably good choice for small ﬁeld dosimetry applications [5–11],
yet care must be taken when selecting between shielded (photon)
and unshielded (electron and stereotactic) diodes. In general, the
correction factors required for shielded diodes are approximately
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irradiation conditions. An experimental procedure for deriving
kfclin ;fmsrQclin ;Qmsr for various diode detectors has been presented by Pantelis
et al. [10]. The method makes use of an error weighted average of
Alanine pellet, thermoluminescent dosimeter (TLD), Gafchromic
EBT ﬁlm and VIP normoxic gel measured relative outputs to derive
a water equivalent output factor. The experimental output factor
can then be used to correct for the well documented diode over-re-
sponse in small ﬁelds. Ralston et al. [11] used an air-core ﬁber optic
scintillation dosimeter (FOD) for small ﬁeld relative output dosim-
etry and showed the FOD can be used to experimentally determine
kfclin ;fmsrQclin ;Qmsr for other detector types. Cranmer-Sargison et al. [14] used
the FOD and diodes to characterize small ﬁelds collimated with a
new 160-leaf MLC. The authors recommend that output ratios
and ﬁeld size be measured concurrently and advocate for the stan-
dard experimental uncertainty on both be quoted when reporting
experimental results.
Monte Carlo (MC) simulation has proven to be a powerful tool
in overcoming the challenges inherent to small ﬁeld dosimetry
[3,4,15–18]. Cranmer-Sargison et al. [12,19] and Francescon et al.
[13,20] have presented MC implementations of the proposed for-
malism and highlight the importance of systematic experimental
validation of the combined accelerator and detector models. Both
authors also explored the sensitivity of MC calculated small ﬁeld
output ratios and kfclin ;fmsrQclin ;Qmsr to the choice of source parameterization
and show the correction factors to be a function of ﬁeld size only.
Further work by Scott et al. [18] has shown that the ratio of dose-
to-water to dose-to-detector-in-water varies signiﬁcantly as a
function of ﬁeld size. For small ﬁeld sizes this ratio correlates with
the mass density of the detector material relative to that of water.
The authors also show that all water dose proﬁles are very similar
to proﬁles simulated with a small isolated silicon volume in water
(also see Francescon et al. [13]).
Regardless of the dosimeter studied, the relative output and
corresponding correction factors appear to have been presented
as a function of the nominal ﬁeld size and not the dosimetric ﬁeld
size. The viability of applying small ﬁeld central axis relative out-
put correction factors to clinically measured data requires stan-
dardization in measurement. In addition to experimental
standardization a ﬁeld size metric, which can be used to appropri-
ately correlate relative output to the measured dosimetric ﬁeld
size, is essential. The suitability of applying published kfclin ;fmsrQclin ;Qmsr cor-
rection factors across a population of linacs is also not apparent
from the literature nor is it clear how the corrections should be ap-
plied to clinical data reported as a function of the measured dosi-
metric ﬁeld size. Each aspect is addressed in the work presented
here.Methods and materials
Deﬁning an effective ﬁeld size for use in small ﬁeld dosimetry
For small ﬁelds collimated with jaws and/or MLCs there can
be a difference between the geometric ﬁeld size and nominal
ﬁeld size as set on the linac console. The difference can be due
to collimator calibration and the positional accuracy of the colli-
mation system itself [5]. Add to this the inherent complication of
the dosimetric ﬁeld size being greater than the geometric ﬁeld
and the requirements for a systematic framework for reporting
and interpreting small ﬁeld dosimetric values becomes clear.
As such, a simple small ﬁeld metric which can be used to repre-
sent the dosimetric ﬁeld size would be of value. A number of ap-
proaches to this are possible but given the magnitude of the
dimensional and scatter component changes which need to be






where A and B correspond to the in-plane and cross-plane dosimet-
ric ﬁeld widths deﬁned as the FWHM at the 50% isodose level.
Moreover, one can deﬁne an equivalent ﬁeld area such that,
FAequ ¼ A  B: ð2Þ
Deﬁning FSeff and FAequ provides a simple yet robust methodo-
logical framework for comparing small ﬁeld dosimetric quantities
across a population of linacs with different collimation systems
(jaws, MLCs and cones, where the FAequ of the latter can be repre-
sented by the actual measured area and the FSeff as the square root
of this). We ﬁrst explore the use of FSeff for small nominally square
ﬁelds and leave the viability of using FAequ for comparison between
cone, jaw and MLC collimated small ﬁelds for another work.Experimental measurements
Small ﬁeld 6 MV relative output measurements were made
using two PTW T60017 unshielded diodes on ﬁve Varian iX linacs
located at three different institutions (See Supplementary Materi-
als for details). Detector speciﬁc output ratios (ORfclindet ) were calcu-
lated with respect to a square jaw collimated ﬁeld of side 3.0 cm
for nominal square jaw collimated ﬁeld sizes of side 1.0, 0.9, 0.8,
0.7, 0.6 and 0.5 cm. Measurements were made at a depth of
5.0 cm with the long axis of the diode detector placed parallel to
the beam axis such that the active volume was positioned at the
isocenter. Positional ﬁne tuning was performed to ensure the ac-
tive volume of the detector was located at the radiation isocenter
and not just centered on the light ﬁeld. Following this method en-
sured the detector positional uncertainty was limited only by accu-
racy of the water tank system quoted by the manufacturer at
±0.1 mm.
The measurements were repeated three times with the water
phantom, detector position and collimation reset between each
experimental session. During each experimental session ﬁve cen-
tral axis output readings and ﬁve in-plane and cross-plane proﬁle
measurements were made at each ﬁeld size. The mean output ratio
and ﬁeld widths were calculated across the three experimental
sessions as were the standard experimental errors for each. FSeff
was calculated using the dosimetric ﬁeld widths along each axis
and ORfclindet values reported as a function of both the nominal and
effective ﬁeld sizes.Monte Carlo simulations
A previously published BEAMnrc model of a 6 MV Varian iX lin-
ear accelerator head [21] was used to create the input phase space
data for all subsequent simulations. The baseline electron source
parameterization was modeled as a 6.2 MeV mono-energetic
Gaussian with a circularly symmetric FWHM = 0.110 cm [12,19].
Simulated machine output per monitor unit was correctly modeled
using the method of Popescu et al. [22] and azimuthal particle
redistribution used to reduce latent phase space uncertainty [23].
DOSRZnrc simulations were run using a previously published
T60017 diode detector model [12] such that the statistical dose
uncertainty scored to the active volume was approximately
±0.5%. The EGSnrc transport parameters ECUT, PCUT and ESTEP
were set to 0.521 and 0.01 MeV and 0.25 respectively. The EXACT
boundary crossing algorithm was used in combination with the
PRESTA-II condensed history electron step algorithm (ESA-
VEIN = 2.0 MeV) and the photon cross-section enhancement vari-
ance reduction technique. Phase space data for jaw collimated
geometric ﬁeld sizes of side 0.40, 0.45, 0.50, 0.55, 0.60, 0.65, 0.70,
0.75, 0.80, 0.85, 0.90, 0.95, 1.0 and 3.0 were used as DOSRZnrc












where DfclindetMC , D
fmsr
detMC
, DfclinmonitorMC and D
fmsr
monitorMC
represent the dose per
incident particle scored to the active volume of the detector model
and linac monitor unit chamber for the fclin and fmsr simulations,
respectively.Fig. 1. Measured ORfclindet data plotted as a function of the nominal (left) and effective (righ
measured output ratios presented in a table form. SCC-0,-1,-2 and QUT-1,-2 are labels for
It should be noted that the output ratio and measured ﬁeld widths for linac SCC-0 are from
ﬁeld width uncertainty.
Fig. 2. DOSXYZnrc simulation data showing the relationship between the dosimetric ﬁe
lower (right) jaws, incident electron energy (top) and FWHM (bottom).DOSXYZnrc simulations were run using the same phase space
data used in the DOSRZnrc simulations. The history number was
set to give a statistical uncertainty of less than ±0.5% within a voxel
dimension of 0.05 cm  0.05 cm  0.25 cm. The in-plane and
cross-plane FWHMs at the 50% level were extracted from the data
and the dosimetric ﬁeld widths plotted as a function of the geo-
metric ﬁeld widths. The sensitivity of FSeff to variations in electron
energy and FWHM were investigated using the two data sets. The
ﬁrst set of data was calculated for an electron energy ﬁxed att) ﬁeld sizes. Shown in the Supplementary Materials are the effective ﬁeld sizes and
the ﬁve Varian iX linacs used in this study (See Supplementary Materials for details).
Cranmer-Sargison et al. [8] and therefore do not include the full characterization in
ld widths plotted as a function of the geometric ﬁeld width for the upper (left) and
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FWHM = 0.100, 0.110, and 0.120 cm. The second set of data was
for electron energies at 5.8, 6.0 and 6.2 MeV with the spatial distri-
bution ﬁxed at a FWHM = 0.110 cm. Once again the dosimetric
ﬁeld widths were extracted from the data and plotted as a function
of geometric ﬁeld widths. For each source parameter combination
ORfclindetMC was plotted as a function of both the nominal and effective
ﬁeld size and the results compared to the experimental data.Interpreting and applying kfclin ;fmsrQclin ;Qmsr
The PTW T60017 diode kfclin ;fmsrQclin ;Qmsr factors published by Cranmer-
Sargison et al. [12] were used to correct the experimental ORfclindet
data in a manner consistent with the Alfonso et al. formalism. It
must be noted that Cranmer-Sargison et al. present the kfclin ;fmsrQclin ;QmsrFig. 3. DOSRZnrc simulated ORfclindet data (solid line) plotted as a function of the nominal ﬁel
shown in Fig. 2. In all cases experimental data are given as a function of the effective ﬁe
does not represent a functional ﬁt.data at the geometric ﬁeld sizes and therefore some question re-
mains as to the appropriateness of applying the corrections (or
similar corrections) to ORfclindet data reported at FSeff . The experimen-
tal ORfclindet data were corrected using the k
fclin ;fmsr
Qclin ;Qmsr
as published at the
geometric ﬁeld sizes and kfclin ;fmsrQclin ;Qmsr reassigned to the effective ﬁeld
sizes calculated from the DOSXYZnrc simulations. In all cases linear
interpolation was used to assign kfclin ;fmsrQclin ;Qmsr to the corresponding
experimental FSeff .Results
Fig. 1 shows the measured ORfclindet data plotted as a function of
the nominal ﬁeld size (as set on the linac console) and the effective
ﬁeld size calculated using the measured in-plane and cross-plane
dosimetric ﬁeld widths. When the ORfclindet data are plotted as a func-d size (left) and effective ﬁeld size (right) calculated for the incident electron FWHM
ld size. The solid line connecting the MC data points is included as a guide only and
354 Reporting corrected small ﬁeld relative outputstion of the nominal ﬁeld size there appears to be a signiﬁcant dif-
ference in the relative output across the linac population, which
could be incorrectly interpreted as being a real difference in the
electron source width incident on the Bremsstrahlung target. How-
ever, when the same ORfclindet data are plotted as a function of FSeff
there is no discernible difference in relative output across the pop-
ulation of linacs. The inference being that the linear accelerators
included in this study have electron source distributions that are
very nearly indistinguishable.
Fig. 2 shows the DOSXYZnrc simulation data that relate the
dosimetric ﬁeld width to the corresponding geometric ﬁeld width
for the upper and lower jaws. These data reveal a number of inter-
esting characteristics: (1) dosimetric ﬁeld widths are greater than
the geometric ﬁeld widths for ﬁeld sizes less than approximately
0.8 cm  0.8 cm, (2) the effect is greater along the axis collimated
by the upper jaw than that collimated by the lower jaw and (3)
the effect is independent of source energy but increases as a func-
tion of increased source width. The dosimetric ﬁeld width data can
be thought of as measured data from a perfect collimator jaw suf-
fering from no positional error or uncertainty and therefore can be
used to elicit the difference between the geometric and dosimetric
ﬁeld widths for this particular accelerator head.
Shown in Fig. 3 are the ORfclindetMC data plotted as a function of both
the geometric (left) and effective (right) ﬁeld sizes. Each graph in-
cludes the experimental ORfclindet data plotted as a function of the
measured effective ﬁeld sizes (see Fig. 1). The ORfclindetMC data simu-
lated using a source FWHM = 0.12 cm, and plotted as a function
of the geometric ﬁeld size, agrees best with the experimental data.
However, ORfclindetMC simulated using a source FWHM = 0.10 cm is
clearly in better agreement if plotted as a function of the effective
ﬁeld size. In both instances the agreement between the experimen-
tal and simulated data is reasonable at a source FWHM = 0.11 cm.
Data in Fig. 4 show the relative output plotted as a function of
the measured effective ﬁeld size corrected using kfclin ;fmsrQclin ;Qmsr values
at the geometric ﬁeld size and the same kfclin ;fmsrQclin ;Qmsr values reassigned
to the associated effective ﬁeld size. Clearly using kfclin ;fmsrQclin ;Qmsr at the
nominal and effective ﬁeld sizes produce output factors that are
not identical but differ by much less than the reported experimen-
tal and/or MC statistical uncertainties. The more important criteria
for using the proposed methodology is to characterize, correct and
report relative output as a function of the effective ﬁeld size and
not the nominal.
Discussion
The measured small ﬁeld relative output data reported as a
function of the nominal ﬁeld size are clearly different across theFig. 4. Corrected relative output data plotted as a function of the measured
effective ﬁeld size. The dashed lines connect the data points and do not represent a
functional ﬁt.accelerator population. However, using the effective ﬁeld size for
reporting showed that the actual output ratios were consistent
across the accelerator population (see Fig. 1). This indicates that
Varian iX accelerators are generally well matched and that any ma-
jor discrepancies in the literature may be attributed to reporting
relative output as a function of the nominal ﬁeld size. Understand-
ing the differences between the nominal, geometric and dosimetric
ﬁeld sizes is critical and the implications, as they relate to inter-
preting small ﬁeld dosimetric data, should not be discounted. For
specialized stereotactic collimators, such as cones or micro-MLCs,
the difference between the dosimetric and geometric ﬁeld widths
will be less than that for upstream jaw collimators. This alone
highlights the importance of establishing a mechanismwhich facil-
itates the presentation of relative output data as a function of the
measured equivalent ﬁeld area.
Reporting measured relative output and dosimetric ﬁeld widths
concurrently is comprehensive but somewhat cumbersome. What
has been shown here is that using FSeff as a small ﬁeld metric re-
lieves much of the ambiguity in reporting and simpliﬁes the mea-
sured dosimetric ﬁeld widths into one representative value. In
addition, adopting a standard experimental methodology that in-
cludes reporting uncertainties in both the effective ﬁeld size and
measured output ratios is vital and consistent with the importance
given to the expression of uncertainties documented in the IAEA
dosimetry code of practice [24].
The Monte Carlo simulations clearly show that the dosimetric
ﬁeld size is larger than the geometric ﬁeld size for small ﬁelds
(as previously reported by Das et al. [3] and Aspradakis et al.
[4]). In all cases the dosimetric ﬁeld width deﬁned by the upper
jaws was larger than that deﬁned by the lower jaws. The upper
jaws are closer to the source when compared to the lower jaws
and therefore require a smaller physical separation to collimate
the same geometric ﬁeld width. The result is greater source occlu-
sion across the upper jaw and therefore an increased effective ﬁeld
size. In short, dosimetric ﬁeld widths increase as a function of in-
creased source occlusion. For the same reason the dosimetric ﬁeld
widths increase as a function of electron spot size increase. The
effective ﬁeld size should therefore be used when tuning the focal
spot size of a linear accelerator Monte Carlo model. As evidenced in
Fig. 3, using the geometric ﬁeld size may result in an incorrect spot
size being determined.
There was a negligible difference in the output factors when
kfclin ;fmsrQclin ;Qmsr was applied using the geometric ﬁeld size or the effective
ﬁeld size. This is consistent with the work of Scott et al. [18] which
showed that a 1.0 mm ﬁeld size difference results in a 1.0% differ-
ence in kfclin ;fmsrQclin ;Qmsr . However, it is recommended that the effective
ﬁeld size be used when assigning kfclin ;fmsrQclin ;Qmsr , as it provides consis-
tency within the proposed methodology and standardizes the
application across a population of linacs.
Presenting small ﬁeld relative output data as a function of the
effective ﬁeld size, as deﬁned is this work, can be well justiﬁed
when one considers the phantom and head scatter factor charac-
teristics of small ﬁelds. McKerracher and Thwaites [25] show that
for square ﬁeld sizes of side <4.0 cm measured phantom scatter
factors are independent of collimation and linac design and depen-
dent only on measurement depth and the beam area irradiated. It
is therefore quite reasonable to argue for the use of FAequ in com-
paring small ﬁeld dosimetric quantities across multiple linacs or
different collimation systems (jaws, MLCs and cones). Head scatter
factors for rectangular ﬁeld sizes have been shown to be dependent
on the collimator exchange effect [26]. However, as Zhu et al. [27]
note, this effect is negligible at ﬁeld sizes of side <2.0 cm, where
source occlusion becomes the dominant effect. Reporting relative
output as a function of the FSeff , which one will recall is calculated
from the measured dosimetric ﬁeld widths, clearly takes into ac-
count differences in source occlusion for millimeter scale changes
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rectangular ﬁeld sizes with sides <2.0 cm would require additional
investigation. Naturally there may be limitations in further appli-
cation of the concepts presented here and in no way should one ap-
ply FAequ or FSeff without rigorous experimental validation.Conclusion
It has been shown that adopting this ﬁeld size metric and the
measurement methodology outlined in this study can provide con-
sistency for small ﬁeld dosimetry across a population of linear
accelerators. However, there could be differences between acceler-
ator designs with greater source occlusion due to a larger focal spot
size, a collimation system closer to the source, or simply a smaller
ﬁeld size.
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